Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Spero ...
bdtonline.com
news
2022-05-31 17:11:10

NEW YORK, May 31, 2022 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a class action lawsuit has been filed against Spero Therapeutics, Inc. ('Spero' or the 'Company') (NASDAQ: SPRO) in the United States District Court for the Eastern District of New York on behalf of investors who purchased Spero stock between October 28, 2021 and May 2, 2022, inclusive (the 'Class Period').On October 28, 20212, Spero announced that it had submitted a New Drug Application ('NDA') to the U.S. Food and Drug Administration ('FDA') for Tebipenem HBr for the Treatment of Complicated Urinary Tract Infections including Pyelonephritis (the 'Tebipenem HBr NDA').
